
AJUNTAMENT D'ALCOI
Website

Generalitat Valenciana
Website

Ayuntamiento de Valencia
Website

Cicloplast
Website

Ayuntamiento de Onil
Website

Anarpla
Website

Ayuntamiento de Mislata
Website

nlWA, North London Waste Authority
Website

Ayuntamiento de Salinas
Website

Zicla
Website

Fondazione Ecosistemi
Website

PEFC
Website

ALQUIENVAS
Website

DIPUTACI� DE VAL�NCIA
Website

AYUNTAMIENTO DE REQUENA
Website

UNIVERSIDAD DE ZARAGOZA
Website

OBSERVATORIO CONTRATACIÓN PÚBLICA
Website

AYUNTAMIENTO DE PAIPORTA
Website

AYUNTAMIENTO DE CUENCA
Website

BERL� S.A.
Website

CM PLASTIK
Website

TRANSFORMADORES INDUSTRIALES ECOL�GICOS

INDUSTRIAS AGAPITO
Website

RUBI KANGURO
Website
If you want to support our LIFE project as a STAKEHOLDER, please contact with us: life-future-project@aimplas.es
In this section, you can access to the latest technical information related to the FUTURE project topic.
PHARMACEUTICAL COMPOSITION FOR EXTENDED RELEASE OF PAIN RELIEF DRUG, AND ADMINISTERING APPARATUS FOR ADMINISTERING SAME
The present invention relates to a pharmaceutical composition for the extended release of a pain relief drug, and an administering device for administering the same, more specifically, to a pharmaceutical composition for the extended release of a pain relief drug, and an administering device for administering the same, the composition comprising: a first composition containing a fibrinogen coagulation promoting factor; and a second composition containing a fibrinogen solution, wherein at least one of the first composition and the second composition comprises a pain relief drug supported on a biodegradable polymer. According to the present invention, the pharmaceutical composition can be directly injection-delivered before suturing a surgical site during operation in a surgical operation, can be fixed to the surgical site, and allows a drug to be delivered, at the fixed location, to a pain site for a long time. In addition, according to the present invention, the pharmaceutical composition can radically extend the lasting period of the efficacy of a drug injected once, and thus the present invention can increase the compliance of a patient and also ultimately achieve an effect of saving drug costs. Furthermore, various types of water-soluble or oil-soluble drugs can be introduced into the pharmaceutical composition according to the present invention, and thus an extended release drug preparation of various uses such as an anti-inflammatory agent, an anticancer drug and a hormone drug, in addition to a use of inhibiting pain, can be developed.

» Number: WO2017034363A1 (A1)
» Publication Date: 02/03/2017
» Applicant: KOREA UNIV RES AND BUSINESS FOUND?[KR]; KIM HYUN KOO?[KR]
» Inventor: KIM HYUN KOO?[KR]; CHOY YOUNG BIN?[KR] (2)
C/ Gustave Eiffel, 4
(València Parc Tecnològic) - 46980
PATERNA (Valencia) - SPAIN
(+34) 96 136 60 40
Project Management department - Sustainability and Industrial Recovery
life-future-project@aimplas.es
